Drugs / PBD-VSEL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06142981 | Sep 2019 → Sep 2022 | — | Fatima Jinnah Medical University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBD-VSEL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06142981 ↗ |
| Known as | peripheral blood derived very small embryonic like | “peripheral blood derived very small embryonic like (PBD-VSEL) stem cells therapy will be done on the 90th day.” NCT06142981 ↗ |
| Action | Restore | “stimulate, replace or repair lost or damaged dopamine-producing cells” NCT06142981 ↗ |
| Modality | Cell therapy | “PBD-VSEL) stem cells therapy” NCT06142981 ↗ |